Stiff person syndrome

Research News


ELEVATE seed grants help researchers at The Ottawa Hospital launch new ideas and collaborations ELEVATE seed grants help researchers at The Ottawa Hospital launch new ideas and collaborations
March 3, 2025 - The grants, worth a total of $198,000, will advance research on muscle disease, stroke, ovarian cancer and scleroderma.
Information for patients: Chemo and blood stem cell transplantation for rare autoimmune diseases Information for patients: Chemo and blood stem cell transplantation for rare autoimmune diseases
January 4, 2017 - A number of media stories have recently highlighted The Ottawa Hospital’s use of chemotherapy and blood stem cell transplantation to treat rare autoimmune diseases, such as myasthenia gravis, stiff person syndrome and scleroderma. These stories have
Researchers in Ottawa achieve breakthrough with rare disease: Stem cells used to send “stiff person syndrome” into long-term remission Researchers in Ottawa achieve breakthrough with rare disease: Stem cells used to send “stiff person syndrome” into long-term remission
August 25, 2014 - Ottawa—Scientists at The Ottawa Hospital Research Institute have made a breakthrough in the successful treatment of a rare and debilitating neurological disease known as stiff person syndrome that leaves people who are afflicted with the disorder sta


Related Resources

Search for clinical trials at The Ottawa Hospital related to this disease or condition.